Hester Biosciences board approves 3 million dollar investment in African arm
New Delhi: Hester Biosciences said its board has approved investing USD 3 million (over Rs 19 crore) in the companys wholly-owned subsidiary, Hester Biosciences Africa limited to ramp up production there.
The company sees a very big potential in Africa for animal vaccines, Hester Biosciences said in a BSE filing.
"The companys board has approved an investment of USD 3 million by way of equity in its wholly-owned subsidiary company - Hester Biosciences Africa Ltd, Tanzania, with an objective to manufacture animal vaccines and health products, to cater to whole African continent", it added.
The amount would be raised through internal accruals of Hester India, Hester Biosciences said.
While the project size has yet to be finalized, the balance amount for the project would be raised through debt.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd